The Cambridge Biogen Inc., the biotechnology giant, invests a one billion dollars ($) for the construction of a new production plant in northern Switzerland, with the aim to triple the global capacity of the company to produce drugs based on proteins known as biologic drugs.
The plant will be located in Luterbach, near Zurich, and will bring 400 new jobs.
The H07BQ-F cables, especially suitable to be used in cold environments, it will be installed and used to power the plant.